evolut manag stage nonseminomat germ-cel tumor testi sequenc treatment modal stage nonseminomat germ-cel cancer evolut treatment past decad lymphadenectomi radiat therapi retroperiton lymphadenectomi nerve-spar retroperiton lymphadenectomi new concept investig patient elig criteria predictor respons relaps primari predictor treatment success local tumor stage statu presenc vascular lymphat invas primari tumor histolog studi critic review accuraci radiolog stage past decad imperfect advent effect chemotherapi improv patient salvag relaps studi qualiti life issu incorpor manag decis conclus manag stage nonseminomat germ-cel cancer one treatment patient treatment advantag disadvantag treatment therefor patient patient emphasi identif relaps risk factor meticul patholog review accur radiolog patient clinic stage unfavor prognost factor presenc vascular invas primari tumor embryon carcinoma tumor retroperiton lymphadenectomi node neg frozen section retroperiton lymphadenectomi nerve-spar retroperiton lymphadenectomi bilater retroperiton lymphadenectomi chanc cure patient stage favor prognost factor tumor teratocarcinoma absenc vascular invas primari tumor suitabl surveil nerve-spar retroperiton lymphadenectomi option patient decis futur effort field number direct fertil paramount issu patient long-term studi necessari chang semen characterist eventu patern patient surveil protocol nerve-spar modifi retroperiton lymphadenectomi improv chemotherapi improv efficaci reduc toxic patholog radiograph serolog predictor site eventu relaps import patient signific risk distant relaps initi chemotherapi protocol abstract truncat AT word 